Development of Quorum-Based Anti-Virulence Therapeutics Targeting Gram-Negative Bacterial Pathogens

Publisher： MDPI

E-ISSN： 1422-0067|14|8|16570-16599

ISSN： 1422-0067

Source： International Journal of Molecular Sciences, Vol.14, Iss.8, 2013-08, pp. : 16570-16599

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting Staphylococcus aureus Toxins: A Potential form of Anti-Virulence Therapy

By Kong Cin Neoh Hui-min Nathan Sheila

Toxins, Vol. 8, Iss. 3, 2016-03 ,pp. : 72-72

MDPI

Access to resources Recommend Favorite

Targeting Bacterial Dsb Proteins for the Development of Anti-Virulence Agents

By Smith Roxanne P. Paxman Jason J. Scanlon Martin J. Heras Begoña

Molecules, Vol. 21, Iss. 7, 2016-07 ,pp. : 811-811

MDPI

Access to resources Recommend Favorite

Gram-Negative Flagella Glycosylation

By Merino Susana Tomás Juan M.

International Journal of Molecular Sciences, Vol. 15, Iss. 2, 2014-02 ,pp. : 2840-2857

MDPI

Access to resources Recommend Favorite

Quorum Quenching Agents: Resources for Antivirulence Therapy

By Tang Kaihao Zhang Xiao-Hua

Marine Drugs, Vol. 12, Iss. 6, 2014-05 ,pp. : 3245-3282

MDPI

Access to resources Recommend Favorite

Marine Compounds with Therapeutic Potential in Gram-Negative Sepsis

By Solov’eva Tamara Davydova Viktoria Krasikova Inna Yermak Irina

Marine Drugs, Vol. 11, Iss. 6, 2013-06 ,pp. : 2216-2229

MDPI

Access to resources Recommend Favorite